Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "I think Biocon will cross Rs 1,000 very soon. Targets of Rs 1,150-1,200 are possible. Its time in the Sun has come as they say so and that is one midcap pharmaceutical stock where you should remain in." "YES Bank will now run but maybe not as much as earlier. However, definitely, it is still in very strong trends," he said. "Again the entire NBFC space, Bajaj Finance, etc all kinds of NBFCs will lead this bull market and easily in Edelweiss Financial Services Rs 130-135 should not be a surprise."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!